Summary
Frail older patients are at risk for adverse consequences from medications or other external stresses. No single marker, such as age or physical disability, or laboratory test can identify this group of patients. As a result, screening questionnaires have been developed and successfully used by nurses to help identify frail older patients upon admission to a hospital. A very short, 7-item screen with questions concerning cognitive ability, physical mobility, nutrition, number of medications used and hospitalisation within the previous month, was able to identify those patients who were more likely to be discharged to a nursing home, die, or incur a large hospitalisation cost for the institution.
While the number of medications used was not an independent predictor of the outcome measures studied (e.g. discharge to a nursing home), data from the literature show that the number of medications prescribed is related to iatrogenic complications in older patients, and specific impairments in mobility and cognition. The proper choice and prescribed dose of a medication is extremely important in frail older patients who, for instance, are at increased risk from hip fracture with some benzodiazepines, and who have markedly diminished clearance of some drugs. A systematic approach is suggested for the prescription of medications in frail older persons which will help achieve optimal pharmacotherapy by using a limited number of medications, thoughtfully selecting medications which will not impair function, and prescribing an appropriate dose based on pharmacodynamic and pharmacokinetic changes that occur with age.
Similar content being viewed by others
References
Avorn J, Dreyer P, Connelly K, Soumerai SB. Use of psychoactive medication and the quality of care in rest homes. New England Journal of Medicine 320: 227–232, 1989
Beers MH, Ouslander JG, Fingolb SF, Morgenstern H, Reuben DB, et al. Inappropriate medication prescribing in skilled nursing facilities. Annals of Internal Medicine 117: 684–689, 1992
Bianchi Porro G, Lazzaroni M. Prescribing policy for antiulcer treatment in the elderly. Drugs & Aging 3(4): 308–319, 1993
Bowman K. Digoxin and the geriatric inpatient. A randomized trial of digoxin vs placebo. Acta Medica Scandanavica 214: 353–360, 1983
Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, et al. Incidence of adverse events and negligence in hospitalized patients. New England Journal of Medicine 324: 370–376, 1991
Reg JL, Gottleib SH, Lakatta EG. Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover trial in patients with normal sinus rhythm. American Journal of Medicine 73: 244–250, 1982
Fretwell MD. Comprehensive functional assessment (CFA) in everyday practice. In Hazzard et al. (Eds) Principles of geriatric medicine, 2nd ed., pp. 218–224, McGraw-Hill Press, New York, 1990a
Fretwell MD. Acute hospital care for frail older patients. In Hazzard et al. (Eds) Principles of geriatric medicine, 2nd ed., pp. 247–253, McGraw-Hill Press, New York, 1990b
Fretwell MD, Raymond PM, McGarvey ST, Sillman RA, Owens NJ, et al. The senior care study: a controlled trial of a consultative/unit-based geriatric assessment program in acute care. Journal of the American Geriatrics Society 38: 1073–1081, 1990
Gosney M, Tallis R. Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital. Lancet 2: 564–567, 1984
Greenblatt DJ, Harmatz JS, Shapiro L, Engelhardt N, Gouthro TA, et al. Sensitivity to triazolam in the elderly. New England Journal of Medicine 324: 1691–1698, 1991
Hanlon JT, Schnader KE, Samsa GP, Weinberger M, Uttech KM, et al. A method for assessing drug therapy appropriateness. Journal of Clinical Epidemiology 45: 1045–1051, 1992
Hindmarsh JJ, Estes EH. Falls in older persons. Causes and interventions. Archives of Internal Medicine 149: 2217–2222, 1989
Hurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Annals of Internal Medicine 114: 956–966, 1991
Katz S, Ford AS, Moskowitz RW. Studies of illness in the aged: the Index of ADL: a standardized measure of biological and psychosocial function. Journal of the American Medical Association 185: 914–924, 1963
Larson EB, Kukull WA, Buchner D, Reifler BV. Adverse drug reactions associated with global cognitive impairment in elderly persons. Annals of Internal Medicine 107: 169–173, 1987
Lawton MP, Moss M, Fulcomer M, Lenban MH. Research and service oriented multilevel assessment instrument. Journal of Gerontology 37: 91–98, 1982
Leape LL, Brennan RA, Laird NM, Lawthers AG, Localio AR, et al. The nature of adverse events in hospitalized patients. New England Journal of Medicine 324: 377–384, 1991
Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. New England Journal of Medicine 321: 303–309, 1989
Murphy SS, Owens NJ, Willey C, Fretwell MD. Development of an emergency room screen to target inpatient services for frail elderly. Abstract. Proceedings of the 48th Annual Meeting of the American Geriatrics Society, Chicago, 1991
Nolan L, O’Malley K. Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions. Journal of the American Geriatrics Society 36: 142–149, 1988
Owens NJ, Silliman RA, Fretwell MD. The relationship between comprehensive functional assessment and optimal pharmacotherapy in the older patient. DICP: Annals of Pharmacotherapy 23: 847–854, 1989
Owens NJ, Sherburne NJ, Silliman RA, Fretwell MD. The Senior Care Study: the optimal use of medications in acutely ill older persons. Journal of the American Geriatrics Society 38: 1082–1087, 1990
Owens NJ, Willey C, Fretwell MD. The association between optimal pharmacotherapy and patient outcome. Pharmacotherapy 11: 7, 1991
Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. New England Journal of Medicine 316: 363–369, 1987
Ray WA, Griffen MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. Journal of the American Medical Association 262: 3303–3307, 1989
Roberts J, Turner N. Pharmacodynamic basis for altered drug action in the elderly. Geriatric Clinics of North America 4: 127–149, 1988
Steel K, Gertman PM, Crescenzi C, Anderson J. Iatrogenic illness on a general medical service at a university hospital. New England Journal of Medicine 304: 638–642, 1981
Solomon D. National Institute of Health Consensus Development Conference Statement: geriatric assessment methods for clinical decision-making. Journal of the American Geriatrics Society 36: 342–347, 1988
Taggart AJ, Johnston GD, McDevitt DG. Digoxin withdrawal after cardiac failure in patients in sinus rhythm. Journal of Cardiovascular Pharmacology 5: 229–234, 1983
Tinetti ME, Williams TF, Mayewski R. Fall risk index for elderly patients based on number of chronic disabilities. American Journal of Medicine 80: 429–434, 1986
Winograd CH, Gerety MD, Chung M, Goldstein MK, Dominguez F, et al. Screening for frailty: criteria and predictors of outcomes. Journal of the American Geriatrics Society 39: 778–784, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Owens, N.J., Fretwell, M.D., Willey, C. et al. Distinguishing Between the Fit and Frail Elderly, and Optimising Pharmacotherapy. Drugs & Aging 4, 47–55 (1994). https://doi.org/10.2165/00002512-199404010-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199404010-00005